	US 11,785,948 B2
	Bacteriophage and composition comprising same
Eun Mi Shin, Seoul (KR); Gi Duk Bae, Seoul (KR); and Jae Won Kim, Yongin-si (KR)
Assigned to CJ CHEILJEDANG CORPORATION, Seoul (KR)
Filed by CJ CHEILJEDANG CORPORATION, Seoul (KR)
Filed on Feb. 27, 2020, as Appl. No. 16/803,710.
Application 16/803,710 is a continuation of application No. 15/303,504, granted, now 10,577,590, previously published as PCT/KR2015/002470, filed on Mar. 13, 2015.
Claims priority of application No. 10-2014-0042911 (KR), filed on Apr. 10, 2014.
Prior Publication US 2020/0190483 A1, Jun. 18, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 63/40 (2020.01); A23K 20/147 (2016.01); A23K 20/10 (2016.01); A23L 2/52 (2006.01); A61K 35/76 (2015.01); C11D 3/48 (2006.01); C12N 7/00 (2006.01); A23K 20/153 (2016.01)

CPC A01N 63/40 (2020.01) [A23K 20/10 (2016.05); A23K 20/147 (2016.05); A23K 20/153 (2016.05); A23L 2/52 (2013.01); A61K 35/76 (2013.01); C11D 3/48 (2013.01); C12N 7/00 (2013.01); A23V 2002/00 (2013.01); C12N 2795/10121 (2013.01); C12N 2795/10131 (2013.01); C12N 2795/10132 (2013.01)]

5 Claims

1. A composition comprising bacteriophage CJ28 deposited under accession number KCCM11466P and a binder selected from the group consisting of lactose, saccharose, sorbitol, mannitol, starch, amylopectin, cellulose, and gelatin, wherein the composition is in a dried state, wherein the bacteriophage ΦCJ28 is present in the composition in an amount of from 5×10¹²pfu/ml to 5×10¹²pfu/ml, and the binder is present in the composition in an amount of from 0.05 parts by weight to 10 parts by weight.